Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 - Slideshow (NASDAQ:CRVS) 2026-01-27
Corvus Pharmaceuticals(US:CRVS) Seeking Alpha·2026-01-28 07:02技术访问问题 - 用户浏览器需启用Javascript和cookie以确保正常访问 [1] - 启用广告拦截器的用户可能被阻止访问 建议禁用广告拦截器并刷新页面 [1]